There are effective antiangiogenesis medications already, so creating one from Ebola would be unnecessary and dangerous. However, it’s not entirely clear whether antiangiogenesis is a viable strategy, since you typically depend on the vasculature to deliver cytotoxins to the tumor. It’s kinda like blowing up the bridge before you cross it.
Answer ( 1 )
There are effective antiangiogenesis medications already, so creating one from Ebola would be unnecessary and dangerous. However, it’s not entirely clear whether antiangiogenesis is a viable strategy, since you typically depend on the vasculature to deliver cytotoxins to the tumor. It’s kinda like blowing up the bridge before you cross it.